Why is Maharashtra FDA Cracking Down on Ayurvedic Drug Makers?
The Maharashtra Food and Drug Administration has launched a statewide crackdown on Ayurvedic drug manufacturers after inspections uncovered serious violations that could affect the quality, safety and efficacy of medicines.
The FDA inspected 434 licensed Ayurvedic manufacturing establishments across Maharashtra. The exercise resulted in 135 show-cause notices, while the licences of 10 firms were permanently cancelled after inspectors found what the regulator considered extremely serious violations.
What triggered the crackdown?
The inspections were conducted to check compliance with the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and Schedule T, which lays down Good Manufacturing Practices for Ayurvedic, Siddha and Unani medicines. The FDA said the most serious violations were significant enough to raise public-health concerns.
What did inspectors find?
The problems went well beyond paperwork. Some manufacturers had no qualified technical personnel, while others were producing medicines without competent technical staff. Several establishments had non-functional quality-control departments or lacked the machinery needed for manufacturing and testing. Inspectors also found unhygienic premises, missing or inconsistent batch and raw-material records, incorrect manufacturing dates on labels and inadequate testing arrangements. Some facilities lacked approved layouts or were operating outside them. Others had no medical examination records for workers, no training records for technical staff and no Control Samples or Master Formula Records, both important elements of pharmaceutical quality control. The FDA also found inadequate safeguards against cross-contamination during manufacturing.
The Age of Anger
31 Jul 2026 - Vol 05 | Issue 31
A raging generation makes the government relent. What's next?
Why do these lapses matter?
Manufacturing controls are meant to ensure that medicines are produced consistently and meet prescribed standards. When testing records are missing, quality-control systems are non-functional or manufacturing conditions are poor, it becomes harder to establish whether a medicine was properly manufactured and tested.
Why were 10 licences cancelled?
The FDA determined that violations at 10 establishments were serious enough to warrant permanent cancellation of their manufacturing licences. The action was ordered by Maharashtra's Ayurvedic Licensing Authority after assessing the violations from the standpoint of medicine quality, safety and efficacy.
What happens to the other manufacturers?
The 135 manufacturers issued show-cause notices have been asked to explain the violations detected during inspections and comply with prescribed requirements.
What is the FDA warning?
FDA Commissioner Tukaram Mundhe said Ayurvedic medicines must be manufactured strictly according to prescribed standards. Manufacturers of classical Ayurvedic medicines must follow recognised reference texts, while patent and proprietary medicines must meet specified quality-control requirements. The FDA has warned that manufacturers failing to comply with Schedule T Good Manufacturing Practices will face strict action. The message is simple: ancient medicine may have ancient roots, but the products reaching consumers must meet modern manufacturing standards.
(With inputs from ANI)